Researchers at the University of Calgary are running a clinical trial to find out whether a cheap, widely available form of ...

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today provides shareholders a ...

A team led by researcher José Vicente Sánchez Mut at the Institute for Neurosciences (IN), a joint center of the Spanish ...

A newly identified molecule called OLE helped restore the brain’s immune cells to a more protective state in Alzheimer’s ...

Watch a subscriber-only discussion exploring longevity's new focus. Billions of dollars are flooding into efforts to reverse ...

Glioblastoma multiforme (GBM) remains one of the most aggressive and treatment-refractory primary brain tumors, with a median ...

The first participant has been treated in a landmark clinical trial of cellular reprogramming, which aims to rejuvenate aging ...

Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.

Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.

Nutrition is increasingly recognized as a central determinant of brain health across the lifespan. Beyond their classical roles as energetic substrates, dietary components and their bioactive ...

Cancer Res (2026) 86 (8_Supplement): LB256. Brain metastases are a lethal complication of cancer, characterized by profound immunosuppression and limited systemic treatment options. Our studies ...